Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susie X Sun

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Annals of Surgical Oncology|June 14, 2021
Contralateral Axillary Metastasis in Patients with Inflammatory Breast CancerLauren M Postlewait, Mediget Teshome, Taiwo Adesoye, et al.
JAMA Network Open|June 25, 2024
Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast ConservationKerollos Nashat Wanis, Henry M Kuerer, Susie X Sun, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 8, 2026
International consensus on axillary staging after neoadjuvant chemotherapy in node-positive breast cancerJames Lucocq, Andreas Karakatsanis, Cliona Kirwan, et al.
JAMA Network Open|September 14, 2023
Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical TrialHelen M Johnson, Heather Lin, Yu Shen, et al.
Therapeutic Advances in Medical Oncology|October 21, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)Bora Lim, Angela Marx, Megumi Kai, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2024
Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast CancerLuisa E Jacomina, David M Swanson, Melissa P Mitchell, et al.
Journal of the National Cancer Institute|March 31, 2025
Development of a Multi-Institutional Dataset to Validate a Novel Inflammatory Breast Cancer Diagnostic ScoreFilipa Lynce, Samuel M Niman, Megumi Kai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2024
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO StudyGiacomo Montagna, Alison Laws, Massimo Ferrucci, et al.
The Lancet. Oncology|December 25, 2025
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort studyGiacomo Montagna, Michael Alvarado, Sara Myers, et al.
JAMA Oncology|April 25, 2024
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant ChemotherapyGiacomo Montagna, Mary M Mrdutt, Susie X Sun, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Annals of Surgical Oncology|June 14, 2021
Contralateral Axillary Metastasis in Patients with Inflammatory Breast CancerLauren M Postlewait, Mediget Teshome, Taiwo Adesoye, et al.
JAMA Network Open|June 25, 2024
Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast ConservationKerollos Nashat Wanis, Henry M Kuerer, Susie X Sun, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 8, 2026
International consensus on axillary staging after neoadjuvant chemotherapy in node-positive breast cancerJames Lucocq, Andreas Karakatsanis, Cliona Kirwan, et al.
JAMA Network Open|September 14, 2023
Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical TrialHelen M Johnson, Heather Lin, Yu Shen, et al.
Therapeutic Advances in Medical Oncology|October 21, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)Bora Lim, Angela Marx, Megumi Kai, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2024
Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast CancerLuisa E Jacomina, David M Swanson, Melissa P Mitchell, et al.
Journal of the National Cancer Institute|March 31, 2025
Development of a Multi-Institutional Dataset to Validate a Novel Inflammatory Breast Cancer Diagnostic ScoreFilipa Lynce, Samuel M Niman, Megumi Kai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2024
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO StudyGiacomo Montagna, Alison Laws, Massimo Ferrucci, et al.
The Lancet. Oncology|December 25, 2025
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort studyGiacomo Montagna, Michael Alvarado, Sara Myers, et al.
JAMA Oncology|April 25, 2024
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant ChemotherapyGiacomo Montagna, Mary M Mrdutt, Susie X Sun, et al.
Pageof 4